The Aescuvest team has been investing on a deal-by-deal basis in the healthtech sector for over a decade alongside top investors and with a network of family offices and strategic investors.
ACP Healthtech Fund I is the natural progression of crystallizing our best of breed approach learned to date into a fund with a clear view of what our optimal deal is and isn't.
The Aescuvest team has been investing on a deal-by-deal basis in the healthtech sector for over a decade alongside top investors and with a network of family offices and strategic investors.
ACP Healthtech Fund I is the natural progression of crystallizing our best of breed approach learned to date into a fund with a clear view of what our optimal deal is and isn't.
Event Driven Investment Model Regulatory Approval Drives Significant Uptick in Value
Event Driven Investment Model Regulatory Approval Drives Significant Uptick in Value
The investment landscape is vast and varied, demanding a clear and focused approach. Rooted in our deep understanding and experience, we've crystallized our strategy into three key principles.
PRINCIPLE 1
PRINCIPLE 1
Be there when it happens
Multiples can be locked in via investments pre-regulatory approval.
PRINCIPLE 2
PRINCIPLE 2
We provide a network
We open the doors to a broad network which may support in regulatory / research / commercial / production.
PRINCIPLE 3
PRINCIPLE 3
Prepare for an early exit
Allow for exits in controlled manner with realistic target multiples rather only targeting the elusive high multiple exit that might never come.
Event Driven Investment Model Regulatory Approval Drives Significant Uptick in Value
The investment landscape is vast and varied, demanding a clear and focused approach. Rooted in our deep understanding and experience, we've crystallized our strategy into three key principles.
PRINCIPLE 1
Be there when it happens
Multiples can be locked in via investments pre-regulatory approval.
PRINCIPLE 2
We provide a network
We open the doors to a broad network which may support in regulatory / research / commercial / production.
PRINCIPLE 3
Prepare for an early exit
Allow for exits in controlled manner with realistic target multiples rather only targeting the elusive high multiple exit that might never come.
Pioneering the Future of Healthcare: Redefining the Industry with These Technologies
Pioneering the Future of Healthcare: Redefining the Industry with These Technologies
Pioneering the Future of Healthcare: Redefining the Industry with These Technologies
Detection & Diagnosis
At the intersection of wellbeing & medicine where the patient journey starts before a disease occurs by enabling earlier and more personalized diagnostics
Areas of interest include remote patient monitoring, advanced medical imaging, AI supported diagnostics, etc.
Advanced Therapies Research
Bioinformatics is the new biotech, process automation democratizes the access to personalized therapies
Areas of interest include advanced therapies manufacturing, digital twins/ disease companions, etc.
Smart Medtech
Data-centric, tech-enabled healthcare is disrupting the old-established healthcare industry
Areas of interest include robotics, data-driven surgery, AI-assisted procedures and manufacturing for cost-effective, affordable healthcare, etc.
